Development and Validation of an HPTLC Method for Determination of Olanzapine in Formulations : New Planar Chromatography-Densitometry Methods for Determination of Drug Substances and FormulationsPATEL, Rashmin B; PATEL, Mrunali R; BHATT, Kashyap K et al.Journal of AOAC International. 2010, Vol 93, Num 3, pp 811-819, issn 1060-3271, 9 p.Article

Effects of olanzapine and clozapine on memory acquisition, consolidation and retrieval in mice using the elevated plus maze testMUTLU, Oguz; ULAK, Güner; CELIKYURT, Ipek Komsuoglu et al.Neuroscience letters. 2011, Vol 501, Num 3, pp 143-147, issn 0304-3940, 5 p.Article

Impact clinique des neuroleptiques atypiques : étude prospective sur 6 mois en milieu hospitalier de patients traités par rispéridone ou olanzapine = Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated by risperidone or olanzapineHAMEL, B; COURTET, P; VERGNES, C et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 645-652, issn 0040-5957, 8 p.Article

Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute Agitation in schizophreniaKINON, Bruce J; AHL, Jonna; ROTELLI, Matthew D et al.The American journal of emergency medicine. 2004, Vol 22, Num 3, pp 181-186, issn 0735-6757, 6 p.Article

Hypersensitivity syndrome with olanzapine confirmed by patch testsPREVOST, Philippe; BEDRY, Regis; LACOSTE, Denis et al.EJD. European journal of dermatology. 2012, Vol 22, Num 1, pp 126-127, issn 1167-1122, 2 p.Article

Simultaneous Assay of Olanzapine and Fluoxetine in Tablets by Column High-Performance Liquid Chromatography and High-Performance Thin-Layer ChromatographySHAH, Charmy R; SHAH, Nehal J; SUHAGIA, Bhanubhai N et al.Journal of AOAC International. 2007, Vol 90, Num 6, pp 1573-1578, issn 1060-3271, 6 p.Article

Closed Symposium Practical Issues in Using OlanzapineThe Journal of clinical psychiatry. 1997, Vol 58, issn 0160-6689, 73 p., SUP10Conference Proceedings

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in humanPOUZET, B; MOW, T; KREILGAARD, M et al.Pharmacology, biochemistry and behavior. 2003, Vol 75, Num 1, pp 133-140, issn 0091-3057, 8 p.Article

Clinical trial response and dropout rates with olanzapine versus risperidoneSANTARLASCI, Benedetta; MESSORI, Andrea.The Annals of pharmacotherapy. 2003, Vol 37, Num 4, pp 556-563, issn 1060-0280, 8 p.Article

Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brainAGOSTINHO, Fabiano R; REUS, Gislaine Z; STRINGARI, Roberto B et al.Neuroscience letters. 2011, Vol 487, Num 3, pp 278-281, issn 0304-3940, 4 p.Article

Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidolPARIKH, Vinay; KHAN, Mohammad M; MAHADIK, Sahebarao P et al.Neuroscience letters. 2004, Vol 356, Num 2, pp 135-139, issn 0304-3940, 5 p.Article

Serum ghrelin concentrations in patients receiving olanzapine or risperidoneTOGO, Takashi; HASEGAWA, Koichi; MIURA, Satoshi et al.Psychopharmacologia. 2004, Vol 172, Num 2, pp 230-232, issn 0033-3158, 3 p.Article

Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapineTHEISM, F. M; LINDEN, A; KÖNIG, I. R et al.Journal of neural transmission. 2003, Vol 110, Num 1, pp 111-121, issn 0300-9564, 11 p.Article

Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteersDE BRUIJN, Ellen R. A; SABBE, Bernard G. C; HULSTIJN, Wouter et al.Brain research. 2006, Vol 1105, pp 122-129, issn 0006-8993, 8 p.Conference Paper

Neurological soft signs and positive treatment response to olanzapine in chronic schizophreniaSEVINCOK, Levent; TOPALOGLU, Beyza.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 1, pp 141-143, issn 0278-5846, 3 p.Article

Therapeutic drug monitoring of olanzapine: The combined effect of age, gender, smoking, and comedicationGEX-FABRY, Marianne; BALANT-GORGIA, Androniki E; BALANT, Luc P et al.Therapeutic drug monitoring. 2003, Vol 25, Num 1, pp 46-53, issn 0163-4356, 8 p.Article

Effects of olanzapine on auditory P300 in schizophreniaGONUL, Ali Saffet; SUER, Cem; COBURN, Kerry et al.Progress in neuro-psychopharmacology & biological psychiatry. 2003, Vol 27, Num 1, pp 173-177, issn 0278-5846, 5 p.Article

Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortexGRONIER, Benjamin S; RASMUSSEN, Kurt.Neuroscience letters. 2003, Vol 349, Num 3, pp 196-200, issn 0304-3940, 5 p.Article

Olanzapine-associated neuroleptic malignant syndromeNORGARD, Nick B; STARK, Jennifer E.Pharmacotherapy. 2006, Vol 26, Num 8, pp 1180-1182, issn 0277-0008, 3 p.Article

Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implicationsASHIM, S; WARRINGTON, S; ANDERSON, I. M et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 1, pp 128-132, issn 0269-8811, 5 p.Article

Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot studyTOGO, Takashi; KOJIMA, Katsuo; SHOJI, Mika et al.International clinical psychopharmacology. 2004, Vol 19, Num 1, pp 37-40, issn 0268-1315, 4 p.Article

Mood stabilization and the role of antipsychoticsYATHAM, Lakshmi N.International clinical psychopharmacology. 2002, Vol 17, pp S21-S27, issn 0268-1315, SUP3Conference Paper

Clozapine effective in olanzapine-induced pisa syndromeARORA, Manu; SAMIR KUMAR PRAHARAJ; SARKAR, Sukanto et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2273-2275, issn 1060-0280, 3 p.Article

The effect of olanzapine on craving and alcohol consumptionHUTCHISON, Kent E; RAY, Lara; SANDMAN, Erica et al.Neuropsychopharmacology (New York, NY). 2006, Vol 31, Num 6, pp 1310-1317, issn 0893-133X, 8 p.Article

Results of a naturalistic study of treatment options: Switching atypical antipsychotic drugs or augmenting with valproateCRAMER, Joyce A; SERNYAK, Michael.Clinical therapeutics. 2004, Vol 26, Num 6, pp 905-914, issn 0149-2918, 10 p.Article